These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5955004)

  • 1. [Considerations on the clinical effects of a phenothiazine derivative: propericiazine or Fi 6145].
    Del Monaco S; Annese A
    G Psichiatr Neuropatol; 1966; 94(2):405-15. PubMed ID: 5955004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of a new neuroleptic drug: propericiazine (FI 6145)].
    Grava C; Bressani F
    G Psichiatr Neuropatol; 1966; 94(3):817-26. PubMed ID: 4381171
    [No Abstract]   [Full Text] [Related]  

  • 3. [Selectivity of action of propericiazine in behavior disorders].
    Nardini L; Pistoni A
    Riv Sper Freniatr Med Leg Alien Ment; 1967 Apr; 91(2):569-75. PubMed ID: 4384082
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinical trial with mesoridazine (another phenodiazine derivative).
    Rudy L; Marozas RJ; Sykes D; Smith JA
    Dis Nerv Syst; 1968 Jun; 29(6):412-3. PubMed ID: 4877749
    [No Abstract]   [Full Text] [Related]  

  • 5. [A comparative study of propericiazine in the management of antisocial behavior].
    Ferguson K; Ban TA; Lehmann HE; Lee H
    Union Med Can; 1967 Apr; 96(4):448-9. PubMed ID: 4382825
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical studies with propericiazine].
    Eckmann F; Immich H; Schäpperle O; Schwarz H
    Med Klin; 1966 Jan; 61(4):142-3. PubMed ID: 4383257
    [No Abstract]   [Full Text] [Related]  

  • 7. A controlled trial of propericiazine and chlorpromazine in "behaviour disorders".
    Rajotte P; Giard N; Tétreault L
    Curr Ther Res Clin Exp; 1966 Apr; 8(4):166-74. PubMed ID: 4379671
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electroencephalographic studies of a triflumethyl-phenothiazine derivative].
    Itil TM
    Arzneimittelforschung; 1965 Jul; 15(7):817-9. PubMed ID: 5898686
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of the combination of propericiazine with chlorpromazine in the psychiatric field].
    Ostaptzeff G; Ostaptzeff-Lavoine M
    Ann Med Psychol (Paris); 1965 Dec; 123(5):655-64. PubMed ID: 4379140
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neuleptil (propericiazine)--an correcting drug in behavior disorders. Preliminary report].
    Alapin B; Stańczak T
    Neurol Neurochir Psychiatr Pol; 1966 Oct; 16(10):1167-71. PubMed ID: 4384653
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of propericiazine on behavior disorders of children and adolescents].
    Duche DJ
    Laval Med; 1970 Jun; 41(6):784-8. PubMed ID: 4396436
    [No Abstract]   [Full Text] [Related]  

  • 12. [Assertion possibilities of a test with psychopharmacology].
    Heimann H
    Ther Umsch; 1971 Apr; 28(4):241-5. PubMed ID: 4930183
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical considerations on the use of Mi. 181 in current psychiatric practice].
    Morin J; Avé M
    Ann Med Psychol (Paris); 1966 Jan; 124(1):82-8. PubMed ID: 5904749
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experimentation with a new phenothiazine derivative, propericiazine (Neuleptil), on a group of patients affected by schizophrenia and deliriant psychoses].
    Ghedini G
    Minerva Med; 1967 Jan; 58(6):131-41. PubMed ID: 4381122
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of propericiazine (Neuleptil) on the Rorschach psychodiagnostic test in children during differential treatment].
    Ronco P; Mezzena G; Priora PM
    Minerva Med; 1968 Jul; 59(53):3003-7. PubMed ID: 4386141
    [No Abstract]   [Full Text] [Related]  

  • 16. The neuroleptics. 10. Therapeutic problems.
    Barahona-Fernandes HJ; Cazzullo CL; Cocchi A; Denber HC; Freyhan FA; Klerman GL; Köknel O; Levine J; Saarma J; Sarteschi P; Vinar O; Wittenborn JR
    Mod Probl Pharmacopsychiatry; 1970; 5():148-56. PubMed ID: 4949818
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sociopsychological aspects of the introduction of a new psychotropic drug in a closed hospital service. Methodological reflections concerning 52 patients treated with propericiazine].
    Garneret N; Boissenin JM; Muyard JP
    Encephale; 1965; 54(3):265-83. PubMed ID: 4378570
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
    Madalena JC
    Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of a new tranquilizing agent in pediatrics].
    Hacquaert R
    Rev Port Pediatr Pueric; 1966; 29(1):34-9. PubMed ID: 5944169
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical considerations on the therapeutic effectiveness of a new neuroleptic (clopenthixol). (Preliminary note)].
    Trotta O
    Osp Psichiatr; 1967; 35(4):535-44. PubMed ID: 5607255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.